TS398851570	drug 86 96	atovaquone
TS428851570	sideeffect 100 129	human immunodeficiency virus-
TS298851570	drug 265 275	atovaquone
TS418851570	treatedDisease 292 321	human immunodeficiency virus-
TS348851570	food 403 408	order
TS118851570	treatedDisease 457 487	Pneumocystis carinii pneumonia
TS198851570	mealTime 670 684	overnight fast
TS308851570	sideeffect 839 846	fasting
TS68851570	mealTime 866 881	a high-fat meal
TS78851570	mealTime 903 918	a high-fat meal
TS358851570	drug 928 938	atovaquone
TS158851570	drugEffect 939 945	levels
TS378851570	food 979 985	liquid
TS218851570	food 1401 1405	food
TS228851570	food 1523 1527	food
TS288851570	food 1530 1534	Food
TS238851570	drugEffect 1549 1564	bioavailability
TS208851570	drug 1568 1578	atovaquone
TS138851570	mealTime 1605 1618	fasting state
R1	relation Arg1:TS288851570 Arg2:TS208851570
TS408851570	food 1675 1679	food
TS178851570	drugEffect 1833 1839	levels
TS88851570	food 1890 1894	food
TS38851570	sideeffect 1942 1946	rash
TS128851570	drug 1979 1989	atovaquone
TS168851570	sideeffect 2031 2048	carinii pneumonia
TS368851570	mealTime 2115 2128	fasting state
TS188851570	food 2195 2199	food
TS258851570	sideeffect 2277 2281	rash
T1	dosage 630 633	500
T2	dosage 636 643	1 , 000
T3	dosage 650 660	1 , 500 mg
T4	frequency 688 704	weekly intervals
T5	duration 779 786	14 days
T6	dosage 1496 1506	1 , 000 mg
T7	frequency 1507 1517	once daily
T8	dosage 1647 1657	1 , 000 mg
T9	frequency 1658 1669	twice daily
T10	dosage 1862 1872	1 , 000 mg
T11	frequency 1873 1884	twice daily
T12	dosage 2087 2097	1 , 000 mg
T13	frequency 2098 2109	twice daily
T14	dosage 2154 2164	1 , 000 mg
T15	frequency 2165 2176	twice daily
